Commission Implementing Regulation (EU) 2016/2045 of 23 November 2016 amending Regulation (EU) No 37/2010 as regards the substance gamithromycin (Text with EEA relevance )

• CELEX: Implementing Regulation (EU) 2016/2045
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gamithromycin’ is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRLs

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

‘Gamithromycin

Gamithromycin

All ruminants except bovine

50 μg/kg

Muscle

Not for use in animals producing milk for human consumption

Anti-infectious agents/Antibiotics’

50 μg/kg

Fat

300 μg/kg

Liver

200 μg/kg

Kidney

Bovine

20 μg/kg

Fat

200 μg/kg

Liver

100 μg/kg

Kidney

Porcine

100 μg/kg

Muscle

NO ENTRY

100 μg/kg

Skin and fat in natural proportions

100 μg/kg

Liver

300 μg/kg

Kidney